Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,724.40
(
-0.30%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
104.25
(
-2.19%
)
Bitcoin
70,354.05
(
-1.25%
)
News Focus
News Focus
Post# of 257260
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122800
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 199818

Saturday, 05/07/2016 3:08:09 PM

Saturday, May 07, 2016 3:08:09 PM

Post# of 257260
MNTA continues to have strong liquidity:

https://www.sec.gov/Archives/edgar/data/1235010/000110465916118813/a16-6503_110q.htm#CONDENSEDCONSOLIDATEDBALANCESHEE_114413

The 3/31/16 pro forma cash balance was $388.2M; this consisted of: $345.8M of unrestricted cash and marketable securities; $21.7M of collaboration receivables from MYL relating to the companies’ FoB partnership; and $20.7M of restricted cash (mostly related to the Lovenox patent case).

For the remaining nine months of 2016, MNTA’s cash-usage guidance—excluding all revenue from NVS and BXLT, but taking into account R&D reimbursement from MYL—is $120-135M (i.e. $40-45M per quarter).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now